PROCESS VALIDATION PROTOCOL

Diasulin 30/70 100IU/ml SC Injection

(Insulin Human USP 100IU per ml – 30% regular insulin human neutral & 70% Isophane insulin)

PACK: 10 mL Multidose Vial

BATCH SIZE: 50L

PRODUCT CODE:IJ92

Protocol No.: VLD-PQ-Pr-114C

Supersedes: None

ACI Limited
7, Hajeegonj Road, Godnyl
Narayangonj – 1400
Bangladesh
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 2 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

Table of Contents
Sr. Contents Page No.
No.
1. Protocol Approval 3

2. Objective, Scope, Responsibilities 4-5

3. Reference, Cleanliness Zone Requirements 6

4. Qualification and training of personnel 7

5. List of analytical equipments qualification summary 7

6. Batch details, Validation Strategy 8

7. Reason for Validation, Prerequisite for process validation ,Abbreviation 8

8. Qualification of Input Materials 9

9. Details of Working standard, Details of Reference document 10

10. Manufacturing Procedure details:

A) Unit formula 11

B) Manufacturing formula 12-15

C) List of manufacturing equipments 16

D) Manufacturing Procedure & flow Chart 17-18

E) General Instructions, Manufacturing Precaution 19

F) process parameters 19-25

11. Sampling Plan and acceptance Criteria 25-26

12. Deviation Summary 27

13. Details of analytical Data Sheet 28

14. Details of Process Sheet 28

15. Validation Report Summary 29

16. Certificate of Approval 30

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 3 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

1. PROTOCOL APPROVAL
Process validation protocol for Diasulin 30/70 100IU/ml SC Injection(Insulin Human USP 100IU
per ml – 30% regular insulin human neutral & 70% Isophane insulin),10 mL vial of batch size 50 L
has been prepared, reviewed, and approved for execution by personnel from the following
functional departments.

Approval:-

Functional Area Name Signature Date

Prepared By
Product Towfika Islam
Development- Product Development Officer
Validation
Checked & Agreed by By

Quality Control Md.Lutfor Rahman Sarker

Asst. QC Manager

Product Mir Motaher Hossain

Development Product Development Manager

G.M. Faruqe Hossain

Quality Compliance Quality Compliance & Validation Manager
& Validation
Niaz Mohammad Sohel
Production Production Manager (Unit-I)

Reviewed By

Quality Assurance A.B.M. Mahfuz ul Alam

Quality Assurance Manager

Approved By
Production Imam Ahmed Istiak
General Manager Operations

Priyatosh Datta
Quality Assurance Director, Quality Assurance

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 4 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

2. OBJECTIVE
To outline the procedure to be followed to evaluate and qualify the acceptability of manufacturing process
of Diasulin 30/70 100IU/ml SC Injection(Insulin Human USP 100IU per ml – 30% regular insulin human
neutral & 70% Isophane insulin), 10 ml multidose vial of batch size 50 L.
Protocol describes Concurrent process validation to establish documented evidence that the
manufacturing process for Diasulin 30/70 100IU/ml SC Injection (Insulin Human USP 100IU per ml –
30% regular insulin human neutral & 70% Isophane insulin), 10 ml multidose vial of batch size 50L. will
consistently produce a product which meets predetermined specifications and quality attributes.

To compile and review the results of process validation to define the process parameters for future
batches. To define procedure and rationale of this validation.

2. SCOPE
The scope of this document is applicable for the concurrent process validation of three batches using
same set of equipments / aids and process for Human Insulin Isophane Suspension and Human
Insulin Injection, 100 IU/mL, 10 ml multidose vial of batch size 50L manufactured in Narayangonj Parma
Factory at Insulin Project as that of WOCKHARDT, INDIA.
Also applicable for the critical parameters that could either directly or indirectly impact on quality of the
product being manufactured.

2. RESPONSIBILITIES:
In accordance with this protocol, following functional departments are responsible for the preparation and
execution of this validation protocol.

QUALITY ASSURANCE
Executive / designee shall follow the following responsibilities;
 Shall prepare process the validation protocol and report.
 Shall do and ensure the sampling as per the sampling plan.
 Shall check, review and compile the Process Validation Protocol and report.
 Shall review the completed batch records.
 Shall ensure stability studies are conducted as per approved stability protocol.
 Shall investigate , the OOS results.(if any)
 Shall ensure that the personnel involved in the critical operations are trained.
 Shall ensure that cGMP practices are followed during the validation.
 Shall monitor the critical parameters during the process.
Quality Compliance & Validation Manager/ designee shall follow the following responsibilities;
 Shall ensure that the equipment and the supporting system for manufacturing of this product are
qualified and within validated status.
 Shall review process validation protocol and report.
 Quality Assurance Manager shall review the process validation protocol and report.
 Director Quality Assurance shall approve the process validation protocol and report.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 5 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

PRODUCTION
Production Manager / designee shall follow the following responsibilities;
 Shall record/inform any deviation from the process.
 Shall train the personnel involved in the process.
 Shall ensure, with the help of Engineering & validation that all necessary equipments/instruments
for the manufacture of this product is available and qualified/validated or calibrated for use.
 Shall fill batch records online.
 Shall provide support for investigation of OOS result (if any)
 Shall check & agreed the process validation protocol and report.

QUALITY CONTROL
Asst. Quality Control Manager / designee shall follow the following responsibilities;
 Shall analyse the sample as per the approved STPs/specifications
 Prepare the In-process and finished product analysis report
 Shall initiate investigation for any out of specification result.
 Shall review the process validation protocol and report.

PRODUCT DEVELOPMENT
Manager Product Development/ designee shall follow the following responsibilities;

 Shall execute the batch manufacture record.

 Shall execute the process validation protocol.
 Shall train the personnel involved in the process.
 Shall fill batch records online.
 Shall review the Process Validation Protocol and report.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 6 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

3. REFERENCE:

GUIDELINES:
 Guidance for Industry, USFDA: Sterile Drug Products Produced by Aseptic
Processing-Current Good Manufacturing.
DOCUMENTS:
 Validation master Plan: -ACI/VMP/006
 Process Sheet : 7-10-220-00
 Specification & STP No. (In process): QA/IPC-Insulin001/00
 Specification & STP No. (Finished): SN-5610/2
 Active Air Sampling (SOP: SMM-37) & Settle Plate (SOP: 8-03-15-11)
 Observations of operator practices/room condition (SOP: 7-10-259-00)
 Environmental monitoring of aseptic area for temperature , humidity & pressure
differential(SOP: 7-10-167-00) & Surfaces Monitoring (SOP: SMM-09)
 Microbiological review of aseptic manufacturing (SOP: 8-03-15-00)
 Water Sampling (SOP: SMM-64) & Personnel Monitoring (SOP: SMM-09)
 Nonviable particle Monitoring (SOP: SMM-05)
 Entry into & exit SOPs (SOP: 7-10-259-00)

3. CLEANLINESS ZONE REQUIREMENTS:

Activity Zone Area

Dispensing Under class 100 surrounded by class 10,000

Manufacturing & Filtration In class 1000

Filling and sealing
Class 100 surrounded by class 1000.

Corridor
In class 1000

Packaging Un-classified area

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 7 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

Batch No:
4. QUALIFICATION AND TRAINING OF PERSONNEL:

Personnel engaged in the Validation project must have adequate qualification and should be trained in the
basic principles of validation and should be thoroughly briefed about the manufacturing process Diasulin
30/70 100IU/ml SC Injection and the detailed methodology to be adopted for the Performance
Qualification of the process.
A list of the personnel with the qualification and training details should be prepared as per the following
format.

Name Designation Department Trained Signature Signature of

(QA/PD/ on of Trainee Trainer
Production)

5. CALIBRATION & QUALIFICATION STATUS OF EQUIPMENT:

Sr. Equipment Name Code/ Calibrated On Next Due

No Identification Date
No.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 8 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

6. TYPE & BATCH DETAILS OF VALIDATION BATCHES:

A minimum three batch shall be planned for the Concurrent validation project.
The batch details of validation batches shall be planned well in advance.

6. VALIDATION STRATEGY:
For the purpose of validation, it is proposed to run three batches of Human Insulin Isophane Suspension
and Human Insulin Injection; 100 IU/mL; batch size 50L. All the three batches shall be compared to
demonstrate the consistency of the process to produce the product meeting the pre determined
specifications and quality attributes.

7. REASON FOR VALIDATION: New Product

7. PREREQUISITE FOR PROCESS VALIDATION:

1. Facility including the major equipment/instruments & the utilities are qualified.
2. All the raw & Packaging materials are tested as per approved specifications (STP) before use.
3. All measuring devices are calibrated.
4. The area is clean & Complies as per the environmental monitoring SOP & its acceptance Criteria.
5. The process sheet & the approved process validation protocol are available.

7. ABBREVIATIONS
SOP: Standard Operating Procedure.
STP: Standard Test Procedure.
OOS: Out Of Specifications
WFI: Water For Injection.
BET: Bacterial Endotoxin Test.
SIP: Steam In Place.
CIP: Clean In Place.
RM: Raw Material.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 9 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

8. QUALIFICATION OF ACTIVE MATERIALS:

Batch No.:

All the raw materials proposed to be used for the manufacture of validation batches shall have the
following qualification.
1) They must comply with the relevant pharmacopoial & in-house specifications.
2) Preferably the same batch number active principle shall be used for all the validation batches
A list of the personnel with the qualification and training details should be prepared as per the following
format.

Name of Materials Name of Manufacturer Specification # GRN# Release Remarks

status

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 10 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

Batch No. :

9. DETAILS OF REFERENCE MATERIALS / WORKING STANDARDS:

Sl Name of materials Code No. Manufacturer GRN NO.

No.

Sl Name Batch No. Strength Exp.Date

No.

9. DETAILS OF REFERENCE DOCUMENTS:

Sl Title Doc. No. Revision Effective Date

No. No.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 11 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

10. MANUFACTURING PROCEDURE DETAILS:

A) UNIT FORMULA :

Materials Name of materials with Code No. Quantity/ml Overage (%)

Required compendia ref. & code no. (mg)
For

Insulin Human USP 1109002 2

(Recombinant) 3.7091*

Zn (as Zinc Oxide) USP 1126001 NA

0.02754**
Protamine Sulphate USP 1116003 NA
0.259
Disodium Hydrogen USP 1104002 NA
Phosphate 2.08
Anhydrous
Raw Metacresol USP 1113002 NA
1.60
Materials (Distilled)
Glycerine USP 1107004 NA
16.32
Phenol (Distilled) USP 1116002 NA
0.65
Sodium Hydroxide 1119003 NA
USP NF q.s to adjust pH
(1N)
Hydrochloric Acid 1108002 NA
USP NF q.s to adjust pH
(1N)
Water For Injection BP 1123001 q.s to NA
1.0 ml

*based on minimum USP limit for Insulin Human in IU/mg (27.50 IU/mg)
** Calculated qty for total Zinc Ion required for the batch.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 12 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

B) MANUFACTURING FORMULA :

Source: Batch Manufacturing Record Formulation No. FDN-5610

Batch Size: 50.0 Litres, Batch Qty: 4,761 Vials; Batch No. :

Materials Name of materials with Code No. Standard weight Actual weight
Required compendia ref. & code no. (g) (g)
For
Insulin Human USP 1109002
(Recombinant) 185.455*

Zn (as Zinc Oxide) USP 1126001

1.377**
Protamine Sulphate USP 1116003 12.950
Disodium Hydrogen USP 1104002
Phosphate 104.00
Anhydrous
Raw Metacresol USP 1113002
80.00
Materials (Distilled)
Glycerine USP 1107004
816.00
Phenol (Distilled) USP 1116002
32.50
Sodium Hydroxide 1119003
USPNF q.s to adjust pH
(1N)
Hydrochloric Acid 1108002
USPNF q.s to adjust pH
(1N)
Water For Injection BP 1123001 q.s to
50.00 L

*based on minimum USP limit for Insulin Human in IU/mg (27.50 IU/mg)
** Calculated qty for total Zinc Ion required for the batch.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 13 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

CALCULATIONS:
1. Required quantity of Insulin Human with 2% overage per batch as follows:

a) For Calculation from single lot/1st lot:

185.455 × 27.50 27.50 IU/mg is the minimum

W1= g = g
A1 USP limit for Insulin Human;
Total Insulin required/Batch:
Where 'A1' is the potency of Insulin Human in IU/mg of 5100000 IU eqv to
1st lot as it is basis 5100000/27.5/1000=185.455 g

Quantity from the single lot/1st lot = g

b) If required from another lot, the following box is to be Applicable Not Applicable
followed :

(W1–1st Lot Qty) x A1

W2= G = g =
A2
Where 'A2' is the potency of Insulin Human in IU/mg of 2nd lot as it is basis.

Quantity from 2nd lot = g

Total qty(W)= (1st Lot Qty +2nd lot Qty) g = ( + )g = g

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 14 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

2.Required quantity of Zinc Ion per batch as follows(0.00027 mg required for each IU of
Insulin):

0.00027 × 5100000 5100000 IU is the total Insulin

Total Zinc ion required = 1000 G = 1.377 g Human per batch with 2%
overage.
(Cal:1) × B ‘B’ is the Zinc ion content as
Endogenous Zinc ion = G = g
100 %w/w in Insulin Human.

Exogenous Zinc ion req.= (Total Zinc ion required – Endogenous Zinc ion ) g = g

1% of Zinc Solution to be added = (Exogenous Zinc ion X 100) ml = ml

In terms of ZnO, the quantity will be as follows-

ZnO required = (Total Zn ion required – Endogenous Zn ion) x 1.2447 = ______________g

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 15 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

3. Required quantity of Protamine Sulphate per batch as follows (0.296 mg Protamine

Base/100 IU):

LOD (%) of Protamine Sulphate = ______________ Sulphate content (%) of Protamine sulphate
= _____

For Protamine Base Content -

[(100 - %LOD) /100] X [(100 - % Sulphate) / 100] = Protamine Base Content -----(a)

= = -------(a)

So, required quantity of Protamine Sulphate per batch will be =

[0.296 X 70 % of batch size in L = _0.296 x 35 _____ g

(a)

= ________________ g. of Protamine Sulphate.

Total Protamine Sulphate required = g

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 16 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

C. LIST OF MANUFACTURING EQUIPMENT:

Equipment Qualification
Sr. No Equipment Name
Number No.
1. Laminar Air Flow Unit
2. Manufacturing vessel with stirrer-100 L capacity
3. Manufacturing vessel with stirrer-50 L capacity
4. Weighing Balance
5. 20 L Churn vessel – 1 pcs
6. Filter assembly
7. 0.2 micron cartridge filters
8. Autoclave
9. SS bucket 10 liters – 2 pcs
10. Micropipettes 1.0 ml,
11. Spatulas - 5 Nos.
12. Cold Storage Area/Room
13. pH meter
14. Storage vessel – 100 L
15. Storage/ collection vessel for WFI ( 5 – 15) 0 C
16. LAF movable trolley
17. SS Funnel – 02 Nos
18. Pipettes – 5 ml, 10 ml, 20 ml
19. Cold storage Area / Room
20. Glass beaker – 500 ml, 1 L, 2 L.
21. Measuring cylinder – 500 ml , 1 L , 2 L.
22. Silicon Tubing
23. Magnetic stirrer
24. Freezer & Refrigerator – 01 each in the
dispensing room / area

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 17 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

D. MANUFACTURING PROCEDURE AND FLOW DIAGRAM:

Dispensing of Raw Materials and
primary packing materials under LAF.

CIP & SIP of manufacturing tank &

Sterilization of manufacturing
accessories.

Verification of Raw Materials before

manufacturing

Part I
 Distillation of m-Cresol & Phenol
 Collection & chilling of WFI to 5 to 15° C.
 Addition of fresh m-Cresol, Phenol & glycerine to WFI under
stirring.
 Protamine sulphate preparation & addition
 Complete wetting of Insulin API with cold WFI (5-15 ° C)
Sampling
 Preparation & addition of Zinc oxide solution
before filtration
 pH adjustment to 2.96 to 3.40 at 10ºC to 15ºC
 Volume make up

Filtration

Part II
 Distillation of m-Cresol & Phenol
 Collection & chilling of WFI to 5 to 15° C.
Sampling  Addition of fresh m-Cresol, Phenol & glycerine to WFI under
before filtration stirring.
 Addition & dissolution of Disodium Hydrogen Phosphate
anhydrous.
 pH adjustment to 7.70 to 7.90 at 5°C to 15°C
 Volume make up

Filtration
This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 18 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

Sampling after 20
hrs for crystal check Holding of Part I & Part II for 24 hrs. for crystallization

Part III
 Distillation of m-Cresol & Phenol
 Collection & chilling of WFI to 5 to 15° C.
 Addition of fresh m-Cresol, Phenol & glycerine to WFI under
stirring.
 Complete wetting of Insulin API with cold WFI (5-15 ° C)
Sampling before  Preparation & addition of Zinc oxide solution
filtration  Addition & dissolution of Disodium Hydrogen Phosphate
anhydrous.
 Final pH adjustment to 6.90 to 7.50.
 Volume make up

Filtration

Sampling of final Mixing of Part I, II & III

bulk

Decartoning & pre inspection of Vials

Vial washing
Vial washing Machine

Tunnel Sterilizer
Vial depyrogenation
(Temperature & conveyor
speed monitoring)

Sterilisation of rubber stoppers

Sampling of Vial filling machine.

Filling and Sealing of Vials
semi finished
product Fill volume Checking

100 %Visual Inspection of filled /sealed

units & packing
This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 19 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

E) GENERAL INSTRUCTIONS:

1. Keep all containers of raw materials contained in small containers in cleaned material staging
room.
2. Weigh and keep the required quantities of different raw materials with proper labeling into
separate clean polyethylene bags/clean and dried S.S. Container and record the material
reference no. properly on the process sheet.
3. Swab the raw materials container with 70% IMS.
4. Transfer the swabbed raw materials containers to the aseptic manufacturing area on the day
before manufacturing through pass box.
5. The solution must be manufactured, filled and sterilized on the same day. If this is impossible for
technical reason, sterile filtration must be done within 8 hours of manufacture.
6. Process sheet should be used in the non-sterile office room.
7. Only freshly prepared water for injection will be used after QA Release.
8. Ensure that manufacturing, filtration & filling accessories are cleaned & sterilized.

E) MANUFACTURING PRECAUTIONS:

The product will manufacturing &filling with special precautions.

F) PROCESS PARAMETERS:

STAGE 1: DISPENSING

CHECK BEFORE USE –

1. Room to be used: Insulin Manufacturing Area

2. Previous Product: ___________________________ Batch no. ____________________
3. Room cleaned / not cleaned (put tick) □ Cleaned □ Not Cleaned
4. Balance to be used:

i) ID # ______________ a) Calibration □ OK □ Not OK

b) Daily Performance Check □ Ok □ Not OK

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 20 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

ii) ID # ______________ a) Calibration □ OK □ Not OK

b) Daily Performance Check □ OK □ Not OK

5. Scoops are cleaned □ OK □ Not OK

6. Absence of any other material in the dispensing room ensured □ OK □ Not OK
(Dispensed or not dispensed)
7. Check the labels on all raw materials container and ensure that right raw materials are there.

□ Ok □ Not OK

8. Exhaust System □ Off □ On

9. Ensure that manufacturing, filtration & filling accessories are cleaned & sterilized.

□ Ok □ Not OK

STAGE 2: MANUFACTURING PROCESS

CHECK BEFORE MANUFACTURING –

1. Room to be used: Insulin Manufacturing Area

2. Previous Product: ___________________________Batch no. _______________________

3. Check & ensure that Manufacturing, Filtration & Filling Accessories are cleaned & sterilized.

□ OK □ Not OK

4. Check and ensure that right raw materials are there. □ OK □ Not OK
5. Check Primary Packing materials before autoclave and before filling. □ OK □ Not OK
6. Check No of dresses autoclaved before starting operation □ OK □ Not OK
7. Check contact parts after autoclave but before filling □ OK □ Not OK

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 21 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

FOLLOWING IS THE BRIEF PROCESS DESCRIPTION WITH CRITICAL PROCESS

PARAMETERS:

Batch No. :

MANUFACTURING PROCEDURE PART-II (70% PART)

Procedure Process Results Limits

Step-I (Buffer Preparation of Buffer Process (5-15)°C

part) solution Temperature
Mixing Time 10mins

pH 7.70-7.90
Step-II Preparation of Process (60-80)°C
(Insulin part) Protamine Sulphate Temperature
Solution
Mixing Time 5-10mins

Preparation of Process (5-15)°C

Preservative Solution Temperature
Mixing Time 10-15mins
Preparation of Insulin Mixing Time 5-10 mins
Paste

Mixing of insulin part Process (10-15)°C

into preservative Temperature
part/Protamine
Mixing Time 15mins
sulphate part

pH 2.96-3.40

Step-III Mix Step II with Step I Mixing Speed Slow

(Trial Mixing) Solution as 1:1 ratio

pH 7.20-7.45

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 22 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

Procedure Process Results Limits

Step- IV Filtration Prefilter Pore diameter 1.2µm

(Sterilization by Filter Millipore, pore
filtration & Mixing of diameter 0.20 µm,
insulin & Buffer) Hydrolyzed PVDF

Mixing of Insulin & Mixing Time 15mins

Buffer part
Mixing Speed Slow
Step- V crystallization crystal Crystal size and
(crystallization;
shape: Rod shaped
After 20 Hours)
crystals majority with
maximum dimensions
greater than 1 µm but
rarely exceeding 60
µm and free from
large aggregates.

MANUFACTURING PROCEDURE PART-II (30% PART)

Procedure Process Results Limits

Step-I Preparation of Process Temperature (5-15)°C

(Buffer part) Buffer solution
Mixing Time 10mins

Step-II Preparation of Mixing Time 5mins

(Insulin part) Insulin Paste
Mixing of Insulin & Process Temperature (10-15)°C
Buffer part
Mixing Time 5mins

pH 6.90-7.50

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 23 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

FINAL MIXING OF 70% PART & 30% PART:

Procedure Process Results Limits

Final mixing of 70% Filtration of 30% Prefilter Millipore, pore

part + 30% Part Part diameter 1.20 µm,
(through filtration for Hydrolyzed PVDF
sterilization of 30%
part) Filter Millipore, pore
diameter 0.20 µm,
Hydrolyzed PVDF

Final Mixing Mixing Time 10mins

(70% Part +
30% Part)
Mixing Speed Slow

GLASS VIAL & FLIP OFF SEAL WASHING & STERILIZATION:

Procedure Process Results Limits

Clear Glass Vial Sterilizing 250°C

washing & Sterilization Oven Temperature

Time 1 hour

Flip Off Seal Autoclave Temperature 121°C

washing & Sterilization
Time 15mins

FILL THE VIAL ACCORDING TO THE FOLLOWING SPECIFICATION:

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 24 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

Process Results Specifications

Machine Vial Auto Filling & Sealing machine

Fill Volume NLT 10.50 ml

(10.10-10.70ml)

Vials 10 ml clear glass vial (Code: 180011)

Rubber Stopper 13mm Bromobutyl Rubber

stopper(Code: 140005)

Flip off seal 13mm blue colored flip-off seal

(Code:3769)

Relative Humidity 50%-60%

Room Temperature 21°C-25°C

Nitrogen gas Beforehand filling

VISUAL INSPECTION:

Process Results Limits

Satisfactory appearance

Faulty filling and sealing 100% vials should pass

this tests
Adequate volume

Seal integrity and leakage

YIELD:

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 25 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

Yield Results

Theoretical yield

Actual yield

Yield percentage

Actual Yield x 100

= ----------------------------- %
Theoretical Yield

11. SAMPLING & TESTING PLAN, ACCEPTANCE CRITERIA:-

Batch No. :

Sl. Stage Tests Responsibility Results Acceptance Criteria

No.
1 Manufacturing – Appearance QA Clear colour less
Insulin solution solution
pH 2.96-3.40
(Part I)

Assay 195 IU/mL to 220

IU/mL
Manufacturing – Appearance QA Clear colourless
Buffer solution solution
pH 7.70 – 7.90
(Part II)

2. After filtration Appearance QA White milky

15 min mixing of suspension.
Insulin solution pH 7.20-7.45
(Part I) & Buffer
solution
Assay 90 % to 110 %
(Part II)

Sl. Stage Tests Responsibility Results Acceptance Criteria

No.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 26 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

3. After holding of Appearance QA White milky suspension.

20 hrs.
pH 7.20-7.45

Assay 90% to 110 %

Crystal Crystal size and shape: Rod

check shaped crystals majority with
maximum dimensions greater
than 1 µm but rarely
exceeding 60 µm and free
from large aggregates.

4. Manufacturing Appearance QA Clear colourless solution.

Buffered Insulin pH 6.90- 7.50
Regular section
Assay 90 % to 110 %
(Part III)
5. Final Bulk Appearance QA White suspension of rod
sample shaped crystals, free from
( before filling) large aggregates of large
Mixing of (Part I crystals following moderate
& Part II )+ agitation. When examined
Buffered insulin microscopically, insoluble
regular section matter in the suspension is
Part III crystalline and contains not
more than traces of
amorphous material.
pH 6.90- 7.80

Assay 90 % to 110 %
6. Finished For QA As per current STP and FPS.
product complete
sampling(Top, analysis.
Middle,Bottom)

12. DEVIATION SUMMARY:

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 27 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

After careful study of all results a deviation report shall be prepared and documented in the following
format:

PERFORMANCE ACI Limited

QUALIFICATION Narayanganj

DEVIATION
Product : Batch No.:
Process :

Reference :
ANALYTICAL &/OR PROCESS DEVIATION
Problem :

Investigation :

Conclusion :

Prepared by:

Product Development Officer Signature:________________

Date : ________________
Checked by:
Asst. Product Development Manager Signature:________________
Date : ________________
Checked by:
Signature:________________
Quality Assurance Manager Date :________________

Approved by:
Signature:________________
Head, Quality Assurance Date :________________
cc: Head, Production
cc: Product Development

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 28 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

13. DETAILS OF ANALYTICAL DATA SHEET:

All the supporting data shall be attached.

14. DETAILS OF PROCESS SHEET:

Process sheet shall be attached

15. VALIDATION REPORT SUMMARY:

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 29 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

Summary & Discussion and Conclusion & Recommendation as a result of validation study
shall be prepared and documented in the following format:

Batch No.:
Reference :

Summary &Discussion:

Conclusion & Recommendation:

Prepared by:
Product Development Officer Signature:________________
Date : ________________

Product Development Manager Signature:________________

Date : ________________

Quality Assurance Manager Signature:________________

Date :________________

Approved by:

Head, Quality Assurance Signature:________________

Date :________________

cc: Head, Production

cc: Product Development

16. CERTIFICATE OF APPROVAL:

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 30 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

A certificate of approval after review of report shall be prepared and documented in the
following format.

PERFORMANCE ACI Limited

QUALIFICATION Narayanganj

CERTIFICATE OF APPROVAL
Product : Batch No.:
Process :
Reference :

Remarks: Based on all of the study as per the validation protocol no # -------- as per process
sheet # ------------ is considered □ Validated □ Not Validated

Prepared by: Signature:________________

Product Development Officer Date : ________________

Checked by: Signature:________________

Asst.Quality Control Manager Date : ________________

Checked by: Signature:________________

Product Development Manager Date : ________________

Signature:________________
Checked by: Date : ________________
Quality Compliance & Validation Manager
Signature:________________
Checked by: Date : ________________
Production Manager
Reviewed by: Signature:________________
Quality Assurance Manager Date :________________

Approved by: Signature:________________

Head, Quality Assurance Date :________________

cc: Head, Production

cc: Product Development

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 31 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 32 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 33 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 34 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 35 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 36 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 37 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 38 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 39 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 40 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 41 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 42 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

1.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 43 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 44 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 45 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 46 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 Department: Title: Protocol No. VLD-PQ-Pr-114C
Product PROCESS VALIDATION PROTOCOL
Development
Supersedes None
Page No. 47 of 30
Diasulin 30/70 100IU/ml SC
Product:
Injection

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of ACI Limited, 7
Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 QUALITY ASSURACNE, ACI LIMITED,
7, HAJEEGONJ ROAD, GODNYL, NARAYANGONJ-1400

Depar Title: Protocol No.

tment:
Formul PROCESS VALIDATION PROTOCOL
Supersedes: None
ation II

Page No. 48 of 52
Human Insulin Isophane Suspension And Human
Prod
Insulin Injection USP (r-DNA), 100 IU/ml, 10 ML
uct:
Multidose Vial.
 QUALITY ASSURACNE, ACI LIMITED,
7, HAJEEGONJ ROAD, GODNYL, NARAYANGONJ-1400

Department: Title: Protocol No.

Formulation II
PROCESS VALIDATION PROTOCOL
Supersedes: None
Page No. 49 of 52
Human Insulin Isophane Suspension And Human
Product: Insulin Injection USP (r-DNA), 100 IU/ml, 10 ML
Multidose Vial.
 QUALITY ASSURACNE, ACI LIMITED,
7, HAJEEGONJ ROAD, GODNYL, NARAYANGONJ-1400

Department: Title: Protocol No.

Formulation II
PROCESS VALIDATION PROTOCOL
Supersedes: None
Page No. 50 of 52
Human Insulin Isophane Suspension And Human
Product: Insulin Injection USP (r-DNA), 100 IU/ml, 10 ML
Multidose Vial.
 QUALITY ASSURACNE, ACI LIMITED,
7, HAJEEGONJ ROAD, GODNYL, NARAYANGONJ-1400
Department: Title: Protocol No.
Formulation II
PROCESS VALIDATION PROTOCOL
Supersedes: None
Page No. 51 of 52
Human Insulin Isophane Suspension And Human
Product: Insulin Injection USP (r-DNA), 100 IU/ml, 10 ML
Multidose Vial.

This is confidential property of ACI Limited, do not disclose without prior consent from Authorized person of Quality Assurance Department of
ACI Limited, 7 Hajeegonj Road, Godnyl, Narayangonj, Ph: 880-7630496, Fax: 880-9884784, web: www.aci-bd.com
 QUALITY ASSURACNE, ACI LIMITED,
7, HAJEEGONJ ROAD, GODNYL, NARAYANGONJ-1400

Department: Title: Protocol No.

Formulation II
PROCESS VALIDATION PROTOCOL
Supersedes: None
Page No. 52 of 52
Human Insulin Isophane Suspension And Human
Product: Insulin Injection USP (r-DNA), 100 IU/ml, 10 ML
Multidose Vial.